Symbiotec Pharmalab Gets FDA EIR Report For Unit

Business Standard Markets · stocks

Symbiotec Pharmalab has received an EIR from the FDA for its manufacturing unit located in the SEZ. This signifies a positive outcome following the FDA's inspection of the facility. The EIR is a crucial document that indicates the inspection has been completed and provides details on the findings. Receiving a satisfactory EIR is a significant step for pharmaceutical companies seeking to export their products to the United States.